D. E. Shaw & Co., Inc. - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,888,752
-15.8%
207,100
-2.4%
0.00%0.0%
Q2 2023$2,244,473
+7.9%
212,143
+24.7%
0.00%0.0%
Q1 2023$2,080,078
-5.7%
170,080
-4.4%
0.00%0.0%
Q4 2022$2,206,932
-42.2%
177,835
-36.4%
0.00%
-60.0%
Q3 2022$3,817,000
+129.1%
279,459
+207.4%
0.01%
+150.0%
Q2 2022$1,666,000
+62.2%
90,900
+42.3%
0.00%
+100.0%
Q1 2022$1,027,000
-53.8%
63,898
-59.8%
0.00%
-50.0%
Q4 2021$2,225,000
-12.0%
158,934
+17.7%
0.00%0.0%
Q3 2021$2,529,000
-59.4%
135,005
-54.8%
0.00%
-60.0%
Q2 2021$6,234,000
-36.5%
299,010
-13.9%
0.01%
-44.4%
Q1 2021$9,815,000
-48.2%
347,190
-40.2%
0.01%
-47.1%
Q4 2020$18,962,000
+82.2%
580,593
+70.9%
0.02%
+54.5%
Q3 2020$10,406,000
+142.3%
339,631
+28.9%
0.01%
+120.0%
Q2 2020$4,294,000
+148.2%
263,457
+51.6%
0.01%
+66.7%
Q1 2020$1,730,000
-52.2%
173,840
-34.0%
0.00%
-25.0%
Q4 2019$3,619,000
+21.8%
263,220
+34.4%
0.00%0.0%
Q3 2019$2,972,000
+84.0%
195,898
+138.9%
0.00%
+100.0%
Q2 2019$1,615,00082,0040.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders